Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-20

Clinical Trial Update: Nitrous Oxide for Analgesia During Office Urethral Bulking [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for nitrous oxide used for analgesia during office urethral bulking, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrous oxide (nitrous oxide)

Snippet

Sponsor: Baylor Research Institute | Conditions: Pain, Stress Incontinence, Female | Phase 4 | Status: TERMINATED